Contrast-enhanced ultrasound for the characterization of portal vein thrombosis vs tumor-in-vein in HCC patients: a systematic review and meta-analysis.
Jifan ChenJianing ZhuChao ZhangYue SongPintong HuangPublished in: European radiology (2020)
PROSPERO registration number: CRD42019138847 KEY POINTS: • Characterization of portal vein thrombosis (PVT) vs tumor-in-vein (TIV) is critical for HCC staging. • CEUS has an excellent safety profile, provides a real-time analysis without any loss in accuracy compared with CT and MRI. • This meta-analysis demonstrates that contrast-enhanced ultrasound (CEUS) is a suitable method for the detection of PVT and distinction with TIV.
Keyphrases
- contrast enhanced ultrasound
- systematic review
- end stage renal disease
- pulmonary embolism
- contrast enhanced
- ejection fraction
- newly diagnosed
- chronic kidney disease
- magnetic resonance imaging
- lymph node
- computed tomography
- prognostic factors
- randomized controlled trial
- pet ct
- meta analyses
- positron emission tomography
- label free
- image quality
- loop mediated isothermal amplification
- patient reported